The stock of Relx NV (ADR) (NYSE:RENX) hit a new 52-week low and has $14.26 target or 5.00% below today’s $15.01 share price. The 9 months bearish chart indicates high risk for the $32.98 billion company. The 1-year low was reported on Nov, 14 by Barchart.com. If the $14.26 price target is reached, the company will be worth $1.65B less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 47,165 shares traded hands. Relx NV (ADR) (NYSE:RENX) has declined 12.52% since April 12, 2016 and is downtrending. It has underperformed by 17.50% the S&P500.
According to Zacks Investment Research, “RELX NV provides professional information solutions primarily in North America and Europe. The company’s operating segments consists of Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. Risk & Business Information segment provides data and analytics which enable customers to evaluate and manage risk. Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. RELX NV, formerly known as Reed Elsevier NV, is based in Amsterdam, the Netherlands.”
More notable recent Relx NV (ADR) (NYSE:RENX) news were published by: Businesswire.com which released: “Issued on behalf of Reed Elsevier PLC and Reed Elsevier NV: Completion of …” on June 30, 2015, also Marketwatch.com with their article: “Plus the latest data from Realtor.com on 21 home markets across the US” published on January 22, 2011, Seekingalpha.com published: “RELX Is A Great Way To Invest In Big Data (When The Price Is Right)” on September 12, 2015. More interesting news about Relx NV (ADR) (NYSE:RENX) were released by: Seekingalpha.com and their article: “Investigating Reed Elsevier’s Dual-Listing Structure” published on April 18, 2013 as well as Ww2.Cfo.com‘s news article titled: “Streamlining a Two-Headed Monster at RELX” with publication date: September 25, 2015.
RENX Company Profile
RELX NV is a Netherlands firm holding shares in RELX Group plc. RELX Group plc is a global well-known provider of information and analytics for professional and business clients across industries. RELX Group plc serves clients in more than 180 countries. The Firm operates in four market divisions. Scientific, Technical & Medical helps clients advance science and improve healthcare by providing information and analytical solutions that enable them to make critical decisions, enhance productivity and improve outcomes. Risk & Business Analytics provides solutions and decision tools that combine public and industry-specific content with advanced technology and analytics. Legal is a well-known provider of information and analytics to professionals in legal, corporate, government and non-profit organizations. Exhibitions organizes over 500 exhibitions a year, attracting more than seven million attendees. Shareholders in RELX NV own a 47.1% economic interest in RELX Group plc.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.